Abstract
Background
Most previous studies about drug use in the elderly population have either investigated drug use in institutions or in the community-dwelling setting. Hence, very few studies have compared drug use in institutionalized and community-dwelling elderly, maybe because of a lack of sufficiently large databases.
Objective
The aim of the study was to investigate differences in drug use patterns between community-dwelling and institutionalized elderly, after adjustment for age, gender and number of other drugs (used as a proxy for overall co-morbidity).
Methods
We analysed data from individuals aged ≥65 years who filled at least one drug prescription between July and September 2008 and were consequently registered in the Swedish Prescribed Drug Register (n = 1,347,564; 1,260,843 community-dwelling and 86,721 institutionalized elderly). A list of current prescriptions was constructed for every individual on the arbitrarily chosen date 30 September 2008. Outcome measures were the 20 most common drug classes and the 20 most common individual drugs. Logistic regression analysis was used to investigate whether institutionalization was associated with use of these drugs, after adjustment for age, gender and number of other drugs.
Results
Institutionalized elderly were more likely than community-dwelling elderly to use antidepressants, laxatives, minor analgesics, opioids and hypnotics/sedatives, after adjustment for age, gender and number of other drugs. On the contrary, institutionalization was negatively associated with use of lipid modifying agents, angiotensin II antagonists, selective calcium channel blockers, β-blocking agents and ACE inhibitors, after adjustment for age, gender and number of other drugs.
Conclusions
Our results indicate that institutionalized elderly are more likely than community-dwelling elderly to use psychotropics, analgesics and laxatives, but less likely to receive recommended cardiovascular drug therapy, which may indicate a need for implementation of evidence-based guidelines for drug treatment in this vulnerable group of elderly patients. Further research is needed to elucidate to what extent the differences in drug use between community-dwelling and institutionalized elderly are explained by different underlying disease patterns and by different prescribing traditions in the different settings.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Haider SI, Johnell K, Johnell K, Ringbäck Weitoft G, et al. The influence of educational level on polypharmacy and inappropriate drug use: a register-based study of more than 600,000 older people. J Am Geriatr Soc. 2009;57:62–9.
Jyrkkä J, Vartiainen L, Hartikainen S, et al. Increasing use of medicines in elderly persons: a five-year follow-up of the Kuopio 75+ Study. Eur J Clin Pharmacol. 2006;62:151–8.
Nobili A, Franchi C, Pasina L, et al. Drug utilization and polypharmacy in an Italian elderly population: the EPIFARM-elderly project. Pharmacoepidemiol Drug Saf. 2011;20:488–96.
Hajjar ER, Cafiero AC, Hanlon JT. Polypharmacy in elderly patients. Am J Geriatr Pharmacother. 2007;5:345–51.
Shi S, Morike K, Klotz U. The clinical implications of ageing for rational drug therapy. Eur J Clin Pharmacol. 2008;64:183–99.
Bergman A, Olsson J, Carlsten A, et al. Evaluation of the quality of drug therapy among elderly patients in nursing homes. Scand J Prim Health Care. 2007;25:9–14.
Onder G, Pedone C, Landi F, et al. Adverse drug reactions as cause of hospital admissions: results from the Italian Group of Pharmacoepidemiology in the Elderly (GIFA). J Am Geriatr Soc. 2002;50:1962–8.
Lane CJ, Bronskill SE, Sykora K, et al. Potentially inappropriate prescribing in Ontario community-dwelling older adults and nursing home residents. J Am Geriatr Soc. 2004;52:861–6.
Miles RW. Cognitive bias and planning error: nullification of evidence-based medicine in the nursing home. J Am Med Dir Assoc. 2010;11:194–203.
Furu K, Wettermark B, Andersen M, et al. The Nordic countries as a cohort for pharmacoepidemiological research. Basic Clin Pharmacol Toxicol. 2010;106:86–94.
Lau HS, de Boer A, Beuning KS, et al. Validation of pharmacy records in drug exposure assessment. J Clin Epidemiol. 1997;50:619–25.
Johnell K, Fastbom J. Antiepileptic drug use in community-dwelling and institutionalized elderly: a nationwide study of over 1,300,000 older people. Eur J Clin Pharmacol. 2011;67:1069–75.
The Anatomical Therapeutic Chemical (ATC) classification system and the Defined Daily Dose (DDD). Oslo: WHO Collaborating Centre for Drug Statistics Methodology [online]. Available from URL: http://www.whocc.no/ [Accessed 2012 Feb 1].
Johnell K, Fastbom J, Rosen M, et al. Inappropriate drug use in the elderly: a nationwide register-based study. Ann Pharmacother. 2007;41:1243–8.
National Board of Health and Welfare. Care and services to elderly persons. 2008 Jun 30 [in Swedish; online]. Available from URL: http://www.socialstyrelsen.se/publikationer2009/2009-125-2 [Accessed 2012 Jul 13].
Nordberg G, Wimo A, Jonsson L, et al. Time use and costs of institutionalised elderly persons with or without dementia: results from the Nordanstig cohort in the Kungsholmen Project—a population based study in Sweden. Int J Geriatr Psychiatry. 2007;22:639–48.
Schneeweiss S, Seeger JD, Maclure M, et al. Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data. Am J Epidemiol. 2001;154:854–64.
Giron MS, Claesson C, Thorslund M, et al. Drug use patterns in a very elderly population: a seven-year review. Clin Drug Invest. 1999;17:389–98.
Giron MS, Forsell Y, Bernsten C, et al. Psychotropic drug use in elderly people with and without dementia. Int J Geriatr Psychiatry. 2001;16:900–6.
Hosia-Randell H, Pitkala K. Use of psychotropic drugs in elderly nursing home residents with and without dementia in Helsinki, Finland. Drugs Aging. 2005;22:793–800.
Richter T, Mann E, Meyer G, et al. Prevalence of psychotropic medication use among German and Austrian nursing home residents: a comparison of 3 cohorts. J Am Med Dir Assoc. 2012;13(187):e7–13.
Lesen E, Carlsten A, Skoog I, et al. Psychotropic drug use in relation to mental disorders and institutionalization among 95-year-olds: a population-based study. Int Psychogeriatr. 2011;23:1270–7.
Svarstad BL, Mount JK. Chronic benzodiazepine use in nursing homes: effects of federal guidelines, resident mix, and nurse staffing. J Am Geriatr Soc. 2001;49:1673–8.
Sonntag A, Matschinger H, Angermeyer MC, et al. Does the context matter? Utilization of sedative drugs in nursing homes—a multilevel analysis. Pharmacopsychiatry. 2006;39:142–9.
Haasum Y, Fastbom J, Fratiglioni L, et al. Pain treatment in elderly persons with and without dementia: a population-based study of institutionalized and home-dwelling elderly. Drugs Aging. 2011;28:283–93.
Gibson SJ. IASP global year against pain in older persons: highlighting the current status and future perspectives in geriatric pain. Expert Rev Neurother. 2007;7:627–35.
Hosia-Randell H, Suominen M, Muurinen S, et al. Use of laxatives among older nursing home residents in Helsinki, Finland. Drugs Aging. 2007;24:147–54.
Levy CR, Radcliff TA, Williams ET, et al. Acute myocardial infarction in nursing home residents: adherence to treatment guidelines reduces mortality, but why is adherence so low? J Am Med Dir Assoc. 2009;10:56–61.
Allen LA, Hernandez AF, Peterson ED, et al. Discharge to a skilled nursing facility and subsequent clinical outcomes among older patients hospitalized for heart failure. Circ Heart Fail. 2011;4:293–300.
Richardson DM, Bain KT, Diamond JJ, et al. Effectiveness of guideline-recommended cardiac drugs for reducing mortality in the elderly medicare heart failure population: a retrospective, survey-weighted, cohort analysis. Drugs Aging. 2010;27:845–54.
Aronow WS, Rich MW, Goodlin SJ, et al. In-hospital cardiology consultation and evidence-based care for nursing home residents with heart failure. J Am Med Dir Assoc. 2012;13:448–52.
Lapane KL, Spooner JJ, Mucha L, et al. Effect of nonsteroidal anti-inflammatory drug use on the rate of gastrointestinal hospitalizations among people living in long-term care. J Am Geriatr Soc. 2001;49:577–84.
Glew CM, Rentler RJ. Use of proton pump inhibitors and other acid suppressive medications in newly admitted nursing facility patients. J Am Med Dir Assoc. 2007;8:607–9.
Singer DE, Albers GW, Dalen JE, et al. Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition). Chest. 2008;133:546S–92S.
Gross CP, Vogel EW, Dhond AJ, et al. Factors influencing physicians’ reported use of anticoagulation therapy in nonvalvular atrial fibrillation: a cross-sectional survey. Clin Ther. 2003;25:1750–64.
Acknowledgments
We thank the National Board of Health and Welfare for providing data. This research was supported financially by a grant from the Swedish Research Council (dnr 2007-5870). The authors have no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Johnell, K., Fastbom, J. Comparison of Prescription Drug Use between Community-Dwelling and Institutionalized Elderly in Sweden. Drugs Aging 29, 751–758 (2012). https://doi.org/10.1007/s40266-012-0002-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40266-012-0002-7